Non-Immunotherapy Application of LNP-mRNA: Maximizing Efficacy and Safety

Non-Immunotherapy Application of LNP-mRNA: Maximizing Efficacy and Safety

Lipid nanoparticle (LNP) formulated messenger RNA-based (LNP-mRNA) vaccines came into the spotlight as the first vaccines against SARS-CoV-2 virus to be applied worldwide. Long-known benefits of mRNA-based technologies consisting of relatively simple and fast engineering of mRNA encoding for antigen...

Full description

Bibliographic Details
Main Author:	Irena Vlatkovic
Format:	Article
Language:	English
Published:	MDPI AG 2021-05-01
Series:	Biomedicines
Subjects:	lipid nanoparticle LNP-mRNA innate immunity efficacy safety cytokines
Online Access:	https://www.mdpi.com/2227-9059/9/5/530

Similar Items

Development of an mRNA-LNP Vaccine against SARS-CoV-2: Evaluation of Immune Response in Mouse and Rhesus Macaque
by: Alireza Naderi Sohi, et al.
Published: (2021-09-01)

Impact of Ribosome Activity on SARS-CoV-2 LNP – Based mRNA Vaccines
by: Evangelos Tsiambas, et al.
Published: (2021-04-01)

Engineering of the current nucleoside-modified mRNA-LNP vaccines against SARS-CoV-2
by: Javier T. Granados-Riveron, et al.
Published: (2021-10-01)

Nanoparticles containing constrained phospholipids deliver mRNA to liver immune cells in vivo without targeting ligands
by: Zubao Gan, et al.
Published: (2020-09-01)

Functionalized lipid nanoparticles for subcutaneous administration of mRNA to achieve systemic exposures of a therapeutic protein
by: Nigel Davies, et al.
Published: (2021-06-01)

Subcutaneous delivery of FGF21 mRNA therapy reverses obesity, insulin resistance, and hepatic steatosis in diet-induced obese mice
by: Andersson, S., et al.
Published: (2022)

mRNA vaccine for cancer immunotherapy
by: Lei Miao, et al.
Published: (2021-02-01)

Influenza Viruses: Innate Immunity and mRNA Vaccines
by: SangJoon Lee, et al.
Published: (2021-08-01)

Advances in Lipid Nanoparticles for mRNA-Based Cancer Immunotherapy
by: Maria L. Guevara, et al.
Published: (2020-10-01)

Efficient hepatic delivery and protein expression enabled by optimized mRNA and ionizable lipid nanoparticle
by: Tongren Yang, et al.
Published: (2020-12-01)

Intracellular Routing and Recognition of Lipid-Based mRNA Nanoparticles
by: Christophe Delehedde, et al.
Published: (2021-06-01)

Nanoparticles as Adjuvants and Nanodelivery Systems for mRNA-Based Vaccines
by: Iman M. Alfagih, et al.
Published: (2021-12-01)

Nanomaterial Delivery Systems for mRNA Vaccines
by: Michael D. Buschmann, et al.
Published: (2021-01-01)

mRNA in cancer immunotherapy: beyond a source of antigen
by: Lien Van Hoecke, et al.
Published: (2021-03-01)

Nanotechnology-Enabled COVID-19 mRNA Vaccines
by: Yu Gao, et al.
Published: (2021-08-01)

mRNA-Based Vaccines
by: Frank Kowalzik, et al.
Published: (2021-04-01)

Long-term storage of lipid-like nanoparticles for mRNA delivery
by: Pengxuan Zhao, et al.
Published: (2020-06-01)

PEG-OligoRNA Hybridization of mRNA for Developing Sterically Stable Lipid Nanoparticles toward In Vivo Administration
by: Shota Kurimoto, et al.
Published: (2019-04-01)

Advancements in mRNA Encoded Antibodies for Passive Immunotherapy
by: Cailin E. Deal, et al.
Published: (2021-01-01)

Anionic Complex with Efficient Expression and Good Safety Profile for mRNA Delivery
by: Eri Hamada, et al.
Published: (2021-01-01)

Aerosolizable Lipid Nanoparticles for Pulmonary Delivery of mRNA through Design of Experiments
by: Hairui Zhang, et al.
Published: (2020-10-01)

Vaccine mRNA Can Be Detected in Blood at 15 Days Post-Vaccination
by: Angheluta, G., et al.
Published: (2022)

PEGylation of mRNA by Hybridization of Complementary PEG-RNA Oligonucleotides Stabilizes mRNA without Using Cationic Materials
by: Naoto Yoshinaga, et al.
Published: (2021-05-01)

In vivo delivery of CRISPR-Cas9 therapeutics: Progress and challenges
by: Matthew Behr, et al.
Published: (2021-08-01)

How mRNA therapeutics are entering the monoclonal antibody field
by: Lien Van Hoecke, et al.
Published: (2019-02-01)

Tet Proteins Regulate Neutrophil Granulation in Zebrafish through Demethylation of socs3b mRNA
by: Kelly M. Banks, et al.
Published: (2021-01-01)

A Comparison of Plasmid DNA and mRNA as Vaccine Technologies
by: Margaret A. Liu
Published: (2019-04-01)

Immunity of the Saccharomyces cerevisiae SSY5 mRNA to nonsense-mediated mRNA decay.
by: Bessie Wanja Kebaara, et al.
Published: (2014-12-01)

Vaginal Smear TNF-alpha, IL18, TLR4, and GATA3 mRNA Levels Correlate with Local Inflammation
by: Olga Bourmenskaya, et al.
Published: (2014-12-01)

Oral Delivery of Lipid Nanoparticles with siRNA for the Treatment of Intestinal Diseases
by: Ball, Rebecca L.
Published: (2018)

Systemic IL-15, IFN-γ, and IP-10/CXCL10 signature associated with effective immune response to SARS-CoV-2 in BNT162b2 mRNA vaccine recipients
by: Cristina Bergamaschi, et al.
Published: (2021-08-01)

Inactivated Parapoxvirus ovis induces a transient increase in the expression of proinflammatory, Th1-related, and autoregulatory cytokines in mice
by: D. Anziliero, et al.
Published: (2014-02-01)

Review the safety of Covid-19 mRNA vaccines: a review
by: Pratibha Anand, et al.
Published: (2021-05-01)

Lipid Nanoparticles as Delivery Systems for RNA-Based Vaccines
by: Basmah N. Aldosari, et al.
Published: (2021-02-01)

The link between adjacent codon pairs and mRNA stability
by: Yuriko Harigaya, et al.
Published: (2017-05-01)

The Interplay of Eukaryotic mRNA Translation and Degradation
by: Hu, Wenqian
Published: (2010)

mRNA Encoding a Bispecific Single Domain Antibody Construct Protects against Influenza A Virus Infection in Mice
by: Lien Van Hoecke, et al.
Published: (2020-06-01)

The decapping activator Edc3 and the Q/N-rich domain of Lsm4 function together to enhance mRNA stability and alter mRNA decay pathway dependence in Saccharomyces cerevisiae
by: Susanne Huch, et al.
Published: (2016-10-01)

Non-invasive measurement of mRNA decay reveals translation initiation as the major determinant of mRNA stability
by: Leon Y Chan, et al.
Published: (2018-09-01)

Opportunities and Challenges in the Delivery of mRNA-Based Vaccines
by: Abishek Wadhwa, et al.
Published: (2020-01-01)